Free Access
Issue |
Med Sci (Paris)
Volume 36, Number 12, Décembre 2020
m/s / COVID-19
|
|
---|---|---|
Page(s) | 1225 - 1232 | |
Section | M/S Revues | |
DOI | https://doi.org/10.1051/medsci/2020231 | |
Published online | 19 November 2020 |
- https://www.courrierinternational.com/grand-format/voir-lhistoire-des-pandemies-en-infographie. [Google Scholar]
- ImmunoWatch COVID-19, MabDesign : https://www.mabdesign.fr/wp-content/uploads/2020/05/MabDesign-Immunowatch-Special-COVID-19-edition-1.pdf. [Google Scholar]
- Beigel JH, Tomashek MK, Dodd LE, Mehta AK, et al. Remdesivir for the treatment of Covid-19 — Final report. N Engl J Med 2020; NEJMoa2007764. doi: 10.1056/NEJMoa2007764. [Google Scholar]
- Site de l’US Food and Drug Administration (FDA): https://www.fda.gov/drugs/coronavirus-covid-19-drugs/coronavirus-treatment-acceleration-program-ctap. [Google Scholar]
- Site de l’European Medicines Agency (EMA): https://www.ema.europa.eu/en/news/covid-19-how-ema-fast-tracks-development-support-approval-medicines-vaccines. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.